KALA BIO, Inc.
KALA
$3.75
$0.030.81%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -10.83% | -13.84% | -26.76% | -54.72% | -68.38% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.27% | 3.46% | -4.97% | -35.24% | -54.07% |
| Operating Income | -3.27% | -3.46% | 4.04% | 32.54% | 51.87% |
| Income Before Tax | 8.74% | 16.06% | -348.22% | -50.18% | 5.85% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8.74% | 16.06% | -348.22% | -50.18% | 5.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.74% | 16.06% | -348.22% | -50.18% | 5.85% |
| EBIT | -3.27% | -3.46% | 4.04% | 32.54% | 51.87% |
| EBITDA | -3.41% | -3.63% | 3.82% | 32.51% | 51.93% |
| EPS Basic | 38.50% | 45.13% | -17,986.92% | -4.64% | 39.54% |
| Normalized Basic EPS | 33.30% | 49.78% | 52.58% | 66.95% | 72.37% |
| EPS Diluted | 38.50% | 45.13% | -18,581.12% | -3.56% | 39.83% |
| Normalized Diluted EPS | 33.30% | 49.78% | 52.45% | 66.89% | 72.33% |
| Average Basic Shares Outstanding | 56.03% | 52.97% | 46.76% | 56.98% | 59.82% |
| Average Diluted Shares Outstanding | 56.03% | 52.97% | 46.54% | 56.71% | 59.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |